Altria Group, Inc. (MO)

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Altria Group, Inc. (“Altria” or “the Company”) (NYSE: MO). Investors who purchased Altria securities are encouraged to obtain additional information and assist the investigation.

The investigation concerns whether Altria has violated federal securities laws.

Altria Investigation Details

Altria Group, Inc. reported second quarter 2026 financial results that missed Wall Street expectations on both earnings and revenue and lowered its full-year 2026 adjusted diluted earnings per share guidance after previously reaffirming its outlook. On the Company’s April 30, 2026 first quarter earnings call, Chief Financial Officer Sal Mancuso stated, “We reaffirm our expectation to deliver 2026 full-year adjusted diluted EPS in a range of $5.56 to $5.72.” During that same call, Chief Executive Officer Billy Gifford highlighted the Company’s oral nicotine pouch business, describing on! PLUS as “the first and only product authorized under the FDA’s pilot program” and stating that the science supporting the Company’s pending applications “provides a basis for FDA authorization within the 180-day statutory time line.” Following the second quarter results, Altria lowered its full-year earnings outlook. The investigation concerns whether the Company adequately disclosed the regulatory and financial risks associated with its smoke-free product strategy and related FDA authorization expectations. Following this news, Altria Group’s stock price dropped on July 30, 2026.

What’s Next for Altria Investors?

If you are aware of any facts relating to this investigation or purchased Altria securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911

No Cost to Altria Investors

We, Bronstein, Gewirtz & Grossman, LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC For Altria Securities Investigation?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace,” said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Contact Info

Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]

Attorney advertising.
Prior results do not guarantee similar outcomes.